Abstract
Intratumoral immunotherapies aim to trigger local and sys-temic immunologic responses via direct injection of immuno-stimulatory agents with the goal of tumor cell lysis, followed by release of tumor-derived antigens and subsequent activation of tumor-specific effector T cells.
Cite
CITATION STYLE
APA
Hamid, O., Ismail, R., & Puzanov, I. (2020). Intratumoral Immunotherapy—Update 2019. The Oncologist, 25(3), e423–e438. https://doi.org/10.1634/theoncologist.2019-0438
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free